Wedge Capital Management L L P Kal Vista Pharmaceuticals, Inc. Transaction History

Wedge Capital Management L L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$18.44 - $30.89 $846,488 - $1.42 Million	-45,905 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$16.51 - $31.1 $142,085 - $267,646	-8,606 Reduced 15.79%	45,905 $1.31 Million
Q4 2018 Jan 31, 2019	SELL	$16.21 - $24.06 $209,903 - $311,552	-12,949 Reduced 19.2%	54,511 $1.08 Million
Q3 2018 Nov 01, 2018	BUY	$8.0 - $22.11 $539,680 - $1.49 Million	67,460 New	67,460 $1.49 Million

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.